Purpose: To evaluate the association between high doses of 4-aminoquinolone derivatives and loss of visual acuity, visual field defects, and fundus changes. Methods: Prospective study of 86 patients in use of chloroquine or hydroxychloroquine (Plaquinol
â) whose initial visit consisted of visual acuity testing, anterior segment slit lamp examination, indirect ophthalmoscopy, computerized perimetry (red stimulus, program 10.2-central), calculation of the daily and cumulative dose used. Cumulative toxic doses were considered
³100 g for chloroquine and
³300 g for hydroxychloroquine. Results: All examined eighty-six patients were women, the average age was 45.08 years in use of chloroquine (n=13) or hydroxychloroquine (n=73) (Plaquinol
â). There was a marked correlation between the use of medication and decrease in vision (p=0.05) with a relative risk of 0.3 (CI 95% 0.1-1.1). Slit lamp examination of the anterior segment was unremarkable in all patients. Fundus examination of chloroquine patients taking nontoxic doses failed to reveal any abnormalities and 41.7% (n=5) of the patients using toxic doses had fundus abnormalities. In the hydroxychloroquine group, 21.8% (n=13) had fundus abnormalities while using nontoxic doses and only 17.6% (n=3) using toxic doses presented fundus abnormalities. Comparing the patients with and without visual field defect in the chloroquine group (p=0.423) and hydroxychloroquine group (p=0.999), there was no statistical difference between the visual field defect and the drug dosage. Conclusion: Loss of vision was greater in chloroquine patients. This information is relevant to stress the importance of visual acuity testing to follow-up patients treated with 4-aminoquinolone derivatives. The presence of visual field defects was not statistically different between patients on high or low doses of 4-aminoquinolone derivates.
Keywords: Retina; Visual acuity; Visual fields; Fundus oculi; Macula lutea; Retinal diseases; Scotoma; Hydroxychloroquine; Hydroxychloroquine; Chloroquine; Chloroquine; Drug toxicity; Comparative study